These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 36814229

  • 1. Epidemiology and source of infection in cancer patients with febrile neutropenia: an experience from a developing country.
    Joudeh N, Sawafta E, Abu Taha A, Hamed Allah M, Amer R, Odeh RY, Salameh H, Sabateen A, Aiesh BM, Zyoud SH.
    BMC Infect Dis; 2023 Feb 22; 23(1):106. PubMed ID: 36814229
    [Abstract] [Full Text] [Related]

  • 2. Meropenem plus amikacin versus piperacillin-tazobactam plus netilmicin as empiric therapy for high-risk febrile neutropenia in children.
    Aksoylar S, Cetingül N, Kantar M, Karapinar D, Kavakli K, Kansoy S.
    Pediatr Hematol Oncol; 2004 Mar 22; 21(2):115-23. PubMed ID: 15160510
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Antibiotic susceptibility of Gram-negatives isolated from bacteremia in children with cancer. Implications for empirical therapy of febrile neutropenia.
    Castagnola E, Caviglia I, Pescetto L, Bagnasco F, Haupt R, Bandettini R.
    Future Microbiol; 2015 Mar 22; 10(3):357-64. PubMed ID: 25812459
    [Abstract] [Full Text] [Related]

  • 8. Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis.
    Moghnieh R, Estaitieh N, Mugharbil A, Jisr T, Abdallah DI, Ziade F, Sinno L, Ibrahim A.
    Front Cell Infect Microbiol; 2015 Mar 22; 5():11. PubMed ID: 25729741
    [Abstract] [Full Text] [Related]

  • 9. Neutropenic infections: a review of the French Febrile Aplasia Study Group trials in 608 febrile neutropenic patients.
    Marie JP, Vekhoff A, Pico JL, Guy H, Andremont A, Richet H.
    J Antimicrob Chemother; 1998 Jun 22; 41 Suppl D():57-64. PubMed ID: 9688452
    [Abstract] [Full Text] [Related]

  • 10. A change for the antibacterial treatment policy to decrease carbapenem consumption at a haematopoietic stem cell transplantation centre.
    Metan G, Kaynar L, Yozgat N, Elmali F, Kürkçüoglu CA, Alp E, Çetin M.
    Infez Med; 2017 Mar 01; 25(1):33-37. PubMed ID: 28353453
    [Abstract] [Full Text] [Related]

  • 11. Bacterial Isolates and Characteristics of Children With Febrile Neutropenia on Treatment for Cancer at a Tertiary Hospital in Western Kenya.
    Kipchumba SK, Njuguna FM, Nyandiko WM.
    JCO Glob Oncol; 2024 Feb 01; 10():e2300313. PubMed ID: 38301180
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The place of ceftazidime/avibactam and ceftolozane/tazobactam for therapy of haematological patients with febrile neutropenia.
    Clerici D, Oltolini C, Greco R, Ripa M, Giglio F, Mastaglio S, Lorentino F, Pavesi F, Farina F, Liberatore C, Castiglion B, Tassan Din C, Bernardi M, Corti C, Peccatori J, Scarpellini P, Ciceri F, Castagna A.
    Int J Antimicrob Agents; 2021 Jun 01; 57(6):106335. PubMed ID: 33838223
    [Abstract] [Full Text] [Related]

  • 14. Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer.
    Cometta A, Zinner S, de Bock R, Calandra T, Gaya H, Klastersky J, Langenaeken J, Paesmans M, Viscoli C, Glauser MP.
    Antimicrob Agents Chemother; 1995 Feb 01; 39(2):445-52. PubMed ID: 7726513
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Application of the Weighted-Incidence Syndromic Combination Antibiogram (WISCA) to guide the empiric antibiotic treatment of febrile neutropenia in oncological paediatric patients: experience from two paediatric hospitals in Northern Italy.
    Liberati C, Donà D, Maestri L, Petris MG, Barbieri E, Gallo E, Gallocchio J, Pierobon M, Calore E, Zin A, Brigadoi G, Mariani M, Mesini A, Saffioti C, Ugolotti E, Gregori D, Giaquinto C, Castagnola E, Biffi A.
    Ann Clin Microbiol Antimicrob; 2024 Feb 15; 23(1):16. PubMed ID: 38360651
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.